← Leaderboards
Elizabeth O Hexner
University Of Pennsylvania
$881,572
Attributed
$1,546,355
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $338.7K · FY2009–22$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,546,355 · 2
By mechanism
UE5$997,175 · 1
K23$549,180 · 1
Top collaborators
- Stephan A Grupp3 shared
- David A Mankoff3 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Stephen G Emerson$28,932,839
- Stephan A Grupp$7,570,044
- Michael I. Kotlikoff$12,824,600
- Richard Aplenc$9,248,721
- Serge Y Fuchs$17,647,204
Others in their field
Top investigators on “Training”
- Jeffrey P Krischer · University Of South Florida$314,856,919
- Christopher McKay · Battelle Memorial Institute$290,340,771
- Judith S. Currier · University Of California Los Angeles$276,624,848
- Daniel R Kuritzkes · Brigham And Women'S Hospital$258,658,543
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$239,830,683
- Steven E Reis · University Of Pittsburgh At Pittsburgh$232,330,444
Research focus
TrainingProgramsResearch PersonnelScientistBaseCareerClinical TrialsResponseTranslational ResearchCellsHematologyGain Of Function MutationAwardHematologic NeoplasmsErythroid CellsGrowthInhibitor/AntagonistEffective TherapyDoseAllelesBiologyChronic Myeloid LeukemiaAllogenicDrug Delivery Systems
Grant awards (7)
The cell and gene therapy toolkit for junior faculty$338,745
UE5 · FY2022 · CA · contact PI
The cell and gene therapy toolkit for junior faculty$338,745
UE5 · FY2021 · CA · contact PI
The cell and gene therapy toolkit for junior faculty$319,685
UE5 · FY2020 · CA · contact PI
Predictors of therapeutic responsiveness to lestaurtinib in myelofibrosis$137,295
K23 · FY2012 · HL · contact PI
Predictors of therapeutic responsiveness to lestaurtinib in myelofibrosis$137,295
K23 · FY2011 · HL · contact PI
Predictors of therapeutic responsiveness to lestaurtinib in myelofibrosis$137,295
K23 · FY2010 · HL · contact PI
Predictors of therapeutic responsiveness to lestaurtinib in myelofibrosis$137,295
K23 · FY2009 · HL · contact PI